Inaktiver Wert

Oncothyreon Inc (USA) Aktie Nasdaq

Aktien

Dauer

Zeitraum

Stil

Cascadian Therapeutics Announces 2018 Outlook and Recent Progress	04.01.18
Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency	02.01.18
Cascadian Therapeutics Added to the Nasdaq Biotechnology Index	13.12.17
Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer	07.12.17
Cascadian Therapeutics Reports Third Quarter 2017 Financial Results	08.11.17

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	-1,43 %	103 Mrd.
REGENERON PHARMACEUTICALS, INC.	+8,96 %	101 Mrd.
ARGENX SE	+4,40 %	23,07 Mrd.
BIONTECH SE	-12,15 %	22,23 Mrd.
GENMAB A/S	-4,36 %	18,05 Mrd.
WUXI APPTEC CO., LTD.	-39,98 %	17,18 Mrd.
BEIGENE, LTD.	-10,04 %	16,94 Mrd.
NEUROCRINE BIOSCIENCES, INC.	+6,79 %	14,07 Mrd.
SAREPTA THERAPEUTICS, INC.	+38,61 %	12,35 Mrd.